Dr. Georgeson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
225 Jackson St
Bridgewater, NJ 08807Phone+1 908-526-8668Fax+1 908-231-6781
Summary
- Steven E. Georgeson, M.D., joined Medicor Cardiology in July of 1993. He came to Medicor from Temple University Hospital in Philadelphia where he trained in Cardiovascular Disease. Prior to that he completed a fellowship in Clinical Decision Making at Tufts New England Medical Center in Boston and trained in Internal Medicine at Thomas Jefferson University Hospital in Philadelphia. He graduated from New York Medical College in Valhalla, New York with his M.D. degree and from Columbia College in New York with a BA in Computer Science.
Dr. Georgeson has served as the director of the Nuclear Cardiology lab at Medicor since 1993 and has been instrumental in gaining national accreditation for both the nuclear lab and the echocardiography program from the Intersocietal Accreditation Program.
Dr. Georgeson has been actively involved in a number of clinical research projects. He is the Principal Investigator in the pivotal Rocket Trial which evaluated a novel blood thinner (Xarelto) as an alternative to Coumadin for patients in Atrial Fibrillation. He has authored several papers which have appeared in peer-reviewed journals, chapters in textbooks and a column in the local newspaper focusing on cardiovascular issues. His extensive professional associations include fellowship in the American College of Cardiology, and the American College of Physicians. In addition, he is a member of the American College of Nuclear Cardiology and a committee member of the Sports and Exercise Section of the American College of Cardiology. He is board certified by the American Board of Internal Medicine in Internal Medicine and Cardiovascular Disease, and he has twice re-certified in both of those fields. He is also board certified in Nuclear Cardiology from the Certification Council of Nuclear Cardiology.
Dr. Georgeson is actively involved at Somerset Medical Center where he has served as Chief of the Division of Cardiology, Director of the Echocardiography Laboratory, a member at-large on
Education & Training
- Temple University HospitalFellowship, Cardiovascular Disease, 1990 - 1993
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHResidency, Internal Medicine, 1986 - 1989
- New York Medical CollegeClass of 1986
Certifications & Licensure
- NJ State Medical License 1993 - 2025
- PA State Medical License 1987 - 2024
- American Board of Internal Medicine Cardiovascular Disease
- National Board of Physicians and Surgeons Cardiovascular Disease
- National Board of Physicians and Surgeons Internal Medicine
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
- CMS Meaningful Use Stage 1 Certification PrimeSUITE EHR, Greenway Health, LLC, 2012
Publications & Presentations
PubMed
- False-positive thallium-201 myocardial perfusion imaging caused by pectus excavatum.Steven Georgeson
Journal of Nuclear Cardiology. 1998-09-01 - 3 citationsQuadricuspid aortic valve diagnosed by transesophageal echocardiography.Steven Georgeson, Richard M. Neibart
American Heart Journal. 1996-12-01 - 4 citationsEndomyocardial biopsy under transesophageal echocardiographic guidance can be safely performed in the critically III cardiac transplant recipientGerald Pytlewski, Steven Georgeson, James Burke, Valluvan Jeevanandam, Pia S. Pollack
The American Journal of Cardiology. 1994-05-15
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: